Delayed CTLA-4 blockade induced a host-derived anti-leukemic effect in a MiHA-mismatched BMT mouse model, while not inducing GVHD, but an autoimmune syndrome with autoimmune hepatitis and circulating anti-DNA auto-antibodies (47). This evidence concerns the gene CTLA4 and graft versus host disease.